Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Nse Industries S.A.

Start price
Target price
Perf. (%)
€15.70
10.07.21
€18.00
10.07.22
31.21%
11.07.22

Could be worthwhile Investment >10% per year
buy
Ordina NV

Start price
Target price
Perf. (%)
€4.09
10.07.21
-
10.07.22
15.79%
11.07.22

Could be worthwhile Investment >10% per year
buy
Yara International

Start price
Target price
Perf. (%)
€46.38
10.07.21
-
10.07.22
-14.12%
11.07.22

Could be worthwhile Investment >10% per year
High dividend yield expected
Good rating
Fair valuation
buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€69.00
10.07.21
-
10.07.22
-25.94%
11.07.22

Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
Growths faster than the competition
buy
Aspermont Ltd.

Start price
Target price
Perf. (%)
€0.018
10.07.21
€0.000
10.07.22
-21.35%
02.05.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
positive Cash Flow expected
buy
Agra Ventures Ltd.

Start price
Target price
Perf. (%)
€2.10
10.07.21
-
10.07.22
-96.10%
02.05.22

Could be worthwhile Investment >10% per year
Inovio Pharma

Start price
Target price
Perf. (%)
€6.92
10.07.21
€5.80
10.07.22
-6.86%
27.11.21

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Alibaba Health Information Technology Ltd

Start price
Target price
Perf. (%)
€1.71
10.07.21
€0.30
10.07.22
-67.46%
11.06.22

Revenue growth >5% per year expected
Low dividend yield expected
Risky balance sheet
ROE lower than 10% per year
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€1.28
10.07.21
€0.80
10.07.22
-30.80%
20.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
Netlist Inc.

Start price
Target price
Perf. (%)
€5.19
10.07.21
-
10.07.22
35.26%
26.07.21

Probably not worthwhile Investment
CareCloud Inc.

Start price
Target price
Perf. (%)
€6.85
10.07.21
€3.20
10.07.22
-46.86%
11.07.22

Growths slower than the competition
Below average Marketposition
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Adler Real Estate AG

Start price
Target price
Perf. (%)
€12.02
10.07.21
€6.00
10.07.22
-39.77%
11.01.22

Low dividend yield expected
negative Cash Flow expected
Few uniques
Dependend from some customers or products
buy
Antelope Enterprise Hldgs Ltd.

Start price
Target price
Perf. (%)
€3.28
10.07.21
€3.00
10.07.22
-26.22%
21.10.21

Could be worthwhile Investment >10% per year
Fair valuation
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Hexagon Purus As

Start price
Target price
Perf. (%)
€3.87
10.07.21
€4.00
10.07.22
-18.60%
30.07.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Lower EBIT Margin than peer group
buy
Chemocentryx Inc.

Start price
Target price
Perf. (%)
€14.32
10.07.21
€20.00
10.07.22
-12.71%
30.07.21

Lower EBIT Margin than peer group
Very low/no dividend yield expected
negative Cash Flow expected
Bad rating
buy
Powercell Sweden AB

Start price
Target price
Perf. (%)
€20.25
10.07.21
-
10.07.22
17.23%
18.11.21

Below average Marketposition
Business model of the past or high risk
Risky Investment
LM Funding America Inc.

Start price
Target price
Perf. (%)
€3.88
10.07.21
-
10.07.22
-7.73%
24.07.21

Revenue decline/stagnation expected
High valuation
Lower EBIT Margin than peer group
Probably not worthwhile Investment
Riley Exploration Permian Inc.

Start price
Target price
Perf. (%)
€20.60
10.07.21
-
10.07.22
-17.48%
24.07.21

Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Bad rating
Univ. Sec. Instr.

Start price
Target price
Perf. (%)
€5.80
10.07.21
-
10.07.22
-12.93%
24.07.21

Lower EBIT Margin than peer group
Low dividend yield expected
Risky balance sheet
Dependend from some customers or products
Desenio Holding Ab

Start price
Target price
Perf. (%)
€4.49
10.07.21
-
10.07.22
3.08%
24.07.21

EBIT decline/stagnation expected
Bad rating
negative Cash Flow expected
Bad culture
AMC Entertainment Holdings Inc.

Start price
Target price
Perf. (%)
€38.01
10.07.21
€5.00
10.07.22
-62.18%
11.07.22

overvalued
Low dividend yield expected
Few uniques
Dependend from some customers or products
buy
Livent Corp.

Start price
Target price
Perf. (%)
€16.95
10.07.21
€25.00
10.07.22
30.04%
11.07.22

EBIT growth > 30% per year expected
Fair valuation
Differentiated customer and product portfolio
Very low/no dividend yield expected
buy
Fagerhult Ab

Start price
Target price
Perf. (%)
€7.09
10.07.21
-
10.07.22
-29.34%
02.03.22

buy
Bilia AB

Start price
Target price
Perf. (%)
€18.66
10.07.21
-
10.07.22
-40.78%
02.03.22

buy
North American Energy Partners Inc.

Start price
Target price
Perf. (%)
€12.40
10.07.21
-
10.07.22
8.87%
02.03.22